$BIVI what a difference it can make to have a strong ceo: Cuong Do (president & ceo): Former President of Samsung Global Strategy Group and former Chief Strategy Officer for Merck - expect the coming 14 days to be really exciting !!

But doesnt change the fact that we have a very safe and effective drug for alz, much better than competitors with more favorable sub group data likely to follow soon.

$AVXL patients and special interest groups will come to Anavex wanting Blarcamesine! !

Sub group analysis for 50 mg dosing is remarkable.

I think certainly the patient groups will be very interested.

Do not forget they met all endpoints for the 2 groups COMBINED!

$AVXL importantly there a so-called superresponders in the blacarmesine treatment group, they improved in cognition score and these are 84% more than observed without that treatment.

Patient advocate groups will push for approval! !

And these posters are not child’s play they’re very detailed - they pack a lot of information onto one poster so a small group of people must have the results.

What a group, a round of applause in order for the guys/gals who helped make this happen.

Come be part of a friendly group!

No significant toxicity or safety concerns were observed in any of the treatment groups.

Good to hear from the same old group of guys starting to signal the upcoming rally. Lfg!